Pharmacokinetics of tildipirosin in porcine plasma, lung tissue, and bronchial fluid and effects of test conditions on in vitro activity against reference strains and field isolates of Actinobacillus pleuropneumoniae

Journal of Veterinary Pharmacology and Therapeutics

Volumn 36, Issue 2, 2013, Pages 140-153

  Rose, M ^a   Menge, M ^a   Bohland, C ^a   Zschiesche, E ^a   Wilhelm, C ^a   Kilp, S ^a   Metz, W ^a   Allan, M ^a   Ropke R ^a   Nurnberger M ^a  

^a Intervet Innovation GmbH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON DIOXIDE; TILDIPIROSIN;

ACTINOBACILLUS PLEUROPNEUMONIAE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ATMOSPHERE; BACTERIUM ISOLATE; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; HISTOPHILUS SOMNI; IN VITRO STUDY; LUNG PARENCHYMA; MALE; NONHUMAN; PASTEURELLA MULTOCIDA; PH; PORCINE ADENOVIRUS; PRIORITY JOURNAL; RESPIRATORY SYSTEM; SINGLE DRUG DOSE;

ACTINOBACILLUS PLEUROPNEUMONIAE; ANIMALS; ANTI-BACTERIAL AGENTS; AREA UNDER CURVE; BODY FLUIDS; BUFFERS; CARBON DIOXIDE; DRUG RESISTANCE, BACTERIAL; FEMALE; HALF-LIFE; HYDROGEN-ION CONCENTRATION; LUNG; MALE; MOLECULAR STRUCTURE; SPECIMEN HANDLING; SWINE; TYLOSIN;

ACTINOBACILLUS PLEUROPNEUMONIAE; HISTOPHILUS SOMNI; PASTEURELLA MULTOCIDA; SUIDAE; SUS;

EID: 84874940025     PISSN: 01407783     EISSN: 13652885     Source Type: Journal    
DOI: 10.1111/j.1365-2885.2012.01397.x     Document Type: Article

References (36)

1. Anadón, A. & Reeve-Johnson, L. (1999) Macrolide antibiotics, drug interactions and microsomal enzymes: implications for veterinary medicine. Research in Veterinary Science, 66, 197-203.
2. Benchaoui, H.A., Nowakowski, M., Sherington, J., Rowan, T.G. & Sunderland, S.J. (2004) Pharmacokinetics and lung concentrations of tulathromycin in swine. Journal of veterinary Pharmacology and Therapeutics, 27, 203-210.
3. Bossé, J.T., Janson, H., Sheehan, B.J., Beddeck, A.J., Rycroft, A.N., Kroll, J.S. & Langford, P.R. (2002) Actinobacillus pleuropneumoniae: pathobiology and pathogenesis of infection. Microbes and Infection, 4, 225-235.
4. Breznak, J.A. & Costilow, R.N. (2007) Physicochemical factors in growth. In Methods for General and Molecular Microbiology, 3rd edn. Eds Reddy, C.A., Beveridge, T.J., Breznak, J.A., Marzluf, G.A., Schmidt, T.M. & Snyder, L.R., pp. 309-329. ASM Press, Washington, DC.
5. Chiers, K., De Waele, T., Pasmans, F., Ducatelle, R. & Haesebrouck, F. (2010) Virulence factors of Actinobacillus pleuropneumoniae involved in colonization, persistence and induction of lesions in its porcine host. Veterinary Research, 41, 65. DOI: 10.1051/vetres/2010037.
6. CLSI (2001) Development of In Vitro Testing Criteria and Quality Control Parameters; Approved Guideline-Second Edition. CLSI document M23-A2. CLSI (Clinical Laboratory Standards Institute, formerly NCCLS), Wayne, PA.
7. CLSI (2002) Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated from Animals; Approved Standard-Second Edition. CLSI document M31-A2. CLSI (Clinical Laboratory Standards Institute, formerly NCCLS), Wayne, PA.
8. CLSI (2008) Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated from Animals; Approved Standard-Third Edition. CLSI document M31-A3. CLSI (Clinical Laboratory Standards Institute), Wayne, PA.
9. Cox, S.R., McLaughlin, C., Fielder, A.E., Yancey, M.F., Bowersock, T.L., Garcia-Tapia, D., Bryson, L., Lucas, M.J., Robinson, J.A., Nanjiani, I. & Brown, S.A. (2010) Rapid and prolonged distribution of tulathromycin into lung homogenate and pulmonary epithelial lining fluid of Holstein calves following a single subcutaneous administration of 2.5mg/kg body weight. International Journal of Applied Research in Veterinary Medicine, 8, 129-137.
10. EMA (2011) CVMP Assessment Report. Zuprevo (EMEA/V/C/002009). http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Public_assessment_report/veterinary/002009/WC500106577.pdf (date last accessed: 29 September 2011).
11. Emerson, D. & Tang, J. (2007) Nutrition and media. In Methods for General and Molecular Microbiology, 3rd edn. Eds Reddy, C.A., Beveridge, T.J., Breznak, J.A., Marzluf, G.A., Schmidt, T.M. & Snyder, L.R., pp. 200-214. ASM Press, Washington, DC.
12. Evans, N. (2005) Tulathromycin: an overview of a new triamilide antimicrobial for livestock respiratory disease. Veterinary Therapeutics, 6, 83-95.
13. Giguère, S., Huang, R., Malinski, T.J., Dorr, P.M., Tessman, R.K. & Sommerville, B.A. (2011) Disposition of gamithromycin in plasma, pulmonary epithelial lining fluid, bronchoalveolar cells, and lung tissue in cattle. American Journal of Veterinary Research, 72, 326-330.
14. Gladue, R.P., Bright, G.M., Isaacson, R.E. & Newborg, M.F. (1989) In vitro and in vivo uptake of azithromycin (CP-62, 993) by phagocytic cells: possible mechanism of delivery and release at sites of infection. Antimicrobial Agents Chemotherapy, 33, 277-282.
15. Godinho, K.S. (2008) Susceptibility testing of tulathromycin: interpretative breakpoints and susceptibility of field isolates. Veterinary Microbiology, 129, 426-432.
16. Hannon, J.P. (1983) Blood acid-base curve nomogram for immature domestic pigs. American Journal of Veterinary Research, 44, 2385-2390.
17. Kiem, S. & Schentag, J.J. (2008) Interpretation of antibiotic concentration ratios measured in epithelial lining fluid. Antimicrobial Agents Chemotherapy, 52, 24-36.
18. Lees, P., Concordet, D., Aliabadi, F.S. & Toutain, P.L. (2006) Drug selection and optimization of dosage schedules to minimize antimicrobial resistance In Antimicrobial Resistance in Bacteria of Animal Origin. Ed Aarestrup, F.M., pp. 49-60. ASM Press, Washington, DC.
19. McKellar, Q.A., Sanchez Bruni, S.F. & Jones, D.G. (2004) Pharmacokinetic/pharmacodynamic relation ship of antimicrobial drugs used in veterinary medicine. Journal of Veterinary Pharmacology and Therapeutics, 27, 503-514.
20. Messenger, K.M., Papich, M.G. & Blikslager, A.T. (2011) Distribution of enrofloxacin and its active metabolite, using an in vivo ultrafiltration sampling technique after the injection of enrofloxacin to pigs. Journal of Veterinary Pharmacology and Therapeutics, doi:10.1111/j.1365-2885.2011.01338.x.
21. Mouton, J.W., Theuertzbacher, U., Craig, W.A., Tulkens, P.M., Derendorf, H. & Cars, O. (2008) Tissue concentrations: do we ever learn?Journal of Antimicrobial Chemotherapy, 61, 235-237.
22. Müller, M., dela Peña, A. & Derendorf, H. (2004) Issues in pharmacokinetics and pharmacodynamics of anti-infective agents: distribution in tissue. Antimicrobial Agents Chemotherapy, 48, 1441-1453.
23. Nightingale, C.H. (1997) Pharmacokinetics and pharmacodynamics of newer macrolides. Pediatric Infectious Disease Journal, 16, 438-443.
24. Norcia, L.J.L., Silvia, A.M., Santoro, S.L., Retsema, J., Letavic, M.A., Bronk, B.S., Lundy, K.M., Yang, B., Evans, N.A. & Hayashi, S.F. (2004) In vitro microbiological characterization of a novel azalide, two triamilides and an azalide ketal against bovine and porcine respiratory pathogens. The Journal of Antibiotics, 57, 280-288.
25. Pruul, H. & McDonald, P.J. (1992) Potentiation of azithromycin activity against Escherichia coli by human serum ultrafiltrate. Journal of Antimicrobial Therapy, 30, 497-507.
26. Reinhold, P., Hartmann, H. & Constable, P.D. (2010) Characterisation of acid-base abnormalities in pigs experimentally infected with Chlamydia suis. The Veterinary Journal, 184, 212-218.
27. Retsema, J.A., Brennan, L.A. & Girard, A.E. (1991) Effects of environmental factors on the in vitro potency of azithromycin. European Journal of Clinical Microbiology and Infectious Diseases, 10, 834-842.
28. Schluenzen, F., Zarivach, R., Harms, J., Bashan, A., Tocilj, A., Albrecht, R., Yonath, A. & Franceschi, F. (2001) Structural basis for the interaction of antibiotics with the peptidyl transferase centre in eubacteria. Nature, 413, 814-821.
29. Schwarz, S., Silley, P., Simjee, S., Woodford, N., van Duijkeren, E., Johnson, A.P. & Gaastra, W. (2010) Editorial: assessing the antimicrobial susceptibility of bacteria obtained from animals. Journal of Antimicrobial Chemotherapy, 65, 601-604.
30. Scorneaux, B. & Shryock, T.R. (1999) Intracellular accumulation, subcellular distribution, and efflux of tilmicosin in bovine mammary, blood, and lung cells. Journal of Dairy Science, 82, 1202-1212.
31. Sørensen, V., Jorsal, S.E. & Mousing, J. (2006) Disease of the respiratory system. In Diseases of Swine, 9th edn. Eds Straw, B.E., Zimmermann, J.J., D'Allaire, S. & Taylor, D.J. pp. 149-177, Blackwell Publishing, Ames, IA.
32. Staerk, K.D.C. (2000) Epidemiological investigation on the influence of environmental risk factors on respiratory diseases n swine - a literature review. The Veterinary Journal, 159, 37-56.
33. Toutain, P.L. (2009) PK/PD approach for antibiotics: tissue or blood drug levels to predict antibiotic efficacy. Journal of Veterinary Pharmacology and Therapeutics, 32 (Suppl. 1), 19-21.
34. Toutain, P.L., Bousquet-Mélou, A. & Martinez, M. (2007) AUC/MIC: a PK/PD index for antibiotics with a time dimensionless scoring factor?Journal of Antimicrobial Chemotherapy, 60, 1185-1188.
35. Van Bambeke, F. & Tulkens, P.M. (2001) Macrolides: pharmacokinetics and pharmacodynamics. International Journal of Antimicrobial Agents, 18, S17-S23.
36. Venner, M., Peters, J., Höhensteiger, N., Schock, B., Bornhorst, A., Grube, M., Adam, U., Scheuch, E., Weitschies, W., Rosskopf, D., Kroemer, H.K. & Siegmund, W. (2010) Concentration oft the macrolide antibiotic tulathromycin in broncho-alveolar cells is influenced by comedication of rifampicin in foals. Naunyn-Schmiedebergs Archives of Pharmacology, 381, 161-169.